InvestSMART

Chrysos Corporation Limited (ASX: C79) - Announcements

Current share price for C79 : $7.410 0.09 (1.20%)+

ASX company news and announcements for Chrysos Corporation Limited (C79) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Chrysos Corporation Limited (C79) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Chrysos Corporation Limited (C79), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Chrysos Corporation Limited (C79)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$863 Appendix 3Y - Eric Ford 13 May 2024 9:01AM $5.680 $7.410 risen by 30.46%
$863 Appendix 3Y - Kerry Gleeson 13 May 2024 9:00AM $5.680 $7.410 risen by 30.46%
$863 Appendix 3Y - Rob Adamson 13 May 2024 8:56AM $5.680 $7.410 risen by 30.46%
$863 Appendix 3Y - Dirk Treasure 13 May 2024 8:52AM $5.680 $7.410 risen by 30.46%
$863 Application for quotation of securities - C79 13 May 2024 8:49AM $5.680 $7.410 risen by 30.46%
$863 Becoming a substantial holder 10 May 2024 5:26PM $5.680 $7.410 risen by 30.46%
$863 Macquarie Australia Conference Presentation 9 May 2024 8:23AM $5.680 $7.410 risen by 30.46%
$863 Change in substantial holding - Robert Henry Richard Adamson 6 May 2024 4:23PM $5.500 $7.410 risen by 34.73%
$863 Ceasing to be a substantial holder - Chrysos Corporation . 6 May 2024 9:51AM $5.430 $7.410 risen by 36.46%
$863 Application for quotation of securities - C79 6 May 2024 9:08AM $5.430 $7.410 risen by 36.46%
$863 Notice under ASX Listing Rule 3.10A 29 Apr 2024 9:17AM $5.230 $7.410 risen by 41.68%
$863 Shaw and Partners Tech Conference Presentation 29 Apr 2024 8:31AM $5.230 $7.410 risen by 41.68%
$863 Chrysos Quarterly Presentation Q3 FY24 23 Apr 2024 9:02AM $6.870 $7.410 risen by 7.86%
$863 Quarterly Activities - Appendix 4C Cashflow Report 23 Apr 2024 9:01AM $6.870 $7.410 risen by 7.86%
$863 Chrysos PhotonAssay Site Visit Presentation 16 Apr 2024 10:31AM $6.950 $7.410 risen by 6.62%
$863 Change of Principal Administrative Office 12 Apr 2024 11:25AM $7.070 $7.410 risen by 4.81%
$863 Change in substantial holding 10 Apr 2024 4:41PM $7.120 $7.410 risen by 4.07%
$863 Notice of Quarterly Webinar Q3 FY24 9 Apr 2024 9:21AM $6.640 $7.410 risen by 11.60%
$863 ASX Small and Mid-Cap Conference Presentation 27 Mar 2024 9:23AM $6.900 $7.410 risen by 7.39%
$863 Becoming a substantial holder 11 Mar 2024 2:11PM $6.350 $7.410 risen by 16.69%
$863 Chrysos Corporation 1H FY24 Results 22 Feb 2024 10:08AM $6.920 $7.410 risen by 7.08%
$863 Interim Financial Report half-year ended 31 December 2023 22 Feb 2024 10:07AM $6.920 $7.410 risen by 7.08%
$863 1H FY24 Results Presentation 22 Feb 2024 10:06AM $6.920 $7.410 risen by 7.08%
$863 Appendix 4D - HY24 22 Feb 2024 10:05AM $6.920 $7.410 risen by 7.08%
$863 Bell Potter Unearthed Presentation 12 Feb 2024 8:37AM $6.880 $7.410 risen by 7.70%

151 - 175 of 340 results

Page 7 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.